Citation Impact
Citing Papers
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
The Brazilian health system: history, advances, and challenges
2011 Standout
Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial
2009 Standout
Molecular imaging and therapy of atherosclerosis with targeted nanoparticles
2007
Structure and Orientation of Peptide Inhibitors Bound to Beta-amyloid Fibrils
2005
Pathogenesis of type 2 diabetes mellitus
2004
ICU-Acquired Weakness
2007
Multifunctional magnetic nanoparticles for targeted imaging and therapy☆
2008
Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures
2006
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
(Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms
2006
Inhibition of Renal Glucose Reabsorption: A Novel Strategy for Achieving Glucose Control in Type 2 Diabetes Mellitus
2008
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Clinical review: Intensive care follow-up--what has it told us?
2002
Critical illness myopathy and neuropathy
2005
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Effects of Care Coordination on Hospitalization, Quality of Care, and Health Care Expenditures Among Medicare Beneficiaries
2009
Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes
2018
Imaging in the era of molecular oncology
2008 StandoutNature
The relationship between cognitive performance and employment and health status in long-term survivors of the acute respiratory distress syndrome: results of an exploratory study
2001
Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro
2006
Mild Cognitive Impairment
2011 Standout
Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications
2008
One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
2003 Standout
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Intensive care unit-acquired weakness
2010
MUSCLE DYSFUNCTION IN THE INTENSIVE CARE UNIT
1999
Rehospitalizations among Patients in the Medicare Fee-for-Service Program
2009 Standout
Amyotrophic lateral sclerosis
2011 Standout
Sepsis and the systemic inflammatory response syndrome
1996
Severe Sepsis and Septic Shock
2013 Standout
Causes of neuromuscular weakness in the intensive care unit: A study of ninety-two patients
1998
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Amyotrophic lateral sclerosis: A 40-year personal perspective
2009
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial
2013
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
2006
Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness*
2003
SGLT inhibitors in management of diabetes
2013
Sodium–glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy
2014
Muscle weakness in mechanically ventilated patients with severe asthma.
1996
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Prolonged weakness after cisatracurium infusion
1998
Low-Tidal-Volume Ventilation in the Acute Respiratory Distress Syndrome
2007
Neuromuscular Sequelae in Survivors of Acute Lung Injury
2006
Type 2 diabetes
2017 Standout
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders
2000
Hydrocortisone Therapy for Patients with Septic Shock
2008 Standout
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
1992 Standout
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
2011 Standout
Multiplicity of cerebrospinal fluid functions: New challenges in health and disease
2008
Effect of Ipragliflozin (ASP1941), a Novel Selective Sodium-Dependent Glucose Co-Transporter 2 Inhibitor, on Urinary Glucose Excretion in Healthy Subjects
2011
Critical illness polyneuropathy a review of the literature, definition and pathophysiology
1994
The role of the kidneys in glucose homeostasis in type 2 diabetes: Clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors
2014
Recent advances in iron oxide nanocrystal technology for medical imaging☆
2006
The Pathophysiology and Treatment of Sepsis
2003 Standout
The Amyloid State of Proteins in Human Diseases
2012 Standout
Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission Tomography
2008
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation
2011 StandoutNatureNobel
Early versus Late Parenteral Nutrition in Critically Ill Adults
2011 Standout
Molecular polymorphism of Aβ in Alzheimer's disease
2008
FeCo/Graphite Nanocrystals for Multi-Modality Imaging of Experimental Vascular Inflammation
2011
Clinical neurophysiology of ALS
2001
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
2019
Access to health care among status Aboriginal people with chronic kidney disease
2008
Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans
2009 StandoutNobel
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Chronic Kidney Disease
2016 Standout
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Intensive Insulin Therapy in the Medical ICU
2006 Standout
The immunopathogenesis of sepsis
2002 StandoutNature
SGLT-2 inhibitors: Their pleiotropic properties
2016
Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome
2010 Standout
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes
2013
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Atomically Precise Colloidal Metal Nanoclusters and Nanoparticles: Fundamentals and Opportunities
2016 Standout
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
2013
Self-Assembled Monolayers of Thiolates on Metals as a Form of Nanotechnology
2005 Standout
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal ( CANVAS‐R ): A randomized, placebo‐controlled trial
2017
The Septic Syndrome: Definition and Clinical Implications
1989
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
SGLT Inhibitors: a Novel Target for Diabetes
2012
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Graphene-Like Two-Dimensional Materials
2013 Standout
Insulin therapy protects the central and peripheral nervous system of intensive care patients
2005
Ultrasmall particles and nanocomposites: state of the art
2013
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
2015
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
2016
Molecular Magnetic Resonance Imaging in Cardiovascular Medicine
2007
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Integralidade da atenção e integração de serviços de saúde: desafios para avaliar a implantação de um "sistema sem muros"
2004
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
2016
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Empagliflozin improves glycaemic and weight control as add‐on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24‐week, randomized, placebo‐controlled trial
2013
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Works of John Brown being referenced
Delineation of Positron Emission Tomography Imaging Agent Binding Sites on β-Amyloid Peptide Fibrils
2005
CRITICAL ILLNESS POLYNEUROPATHY
1987
Motor neuron disease presenting as acute respiratory failure: Electrophysiological studies
1997
Behaviour of [11C]R(−)‐ and [11C]S(+)‐rolipram in vitro and in vivo, and their use as PET radiotracers for the quantificative assay of PDE4
2005
Evidence for the Presence of Three Distinct Binding Sites for the Thioflavin T Class of Alzheimer's Disease PET Imaging Agents on β-Amyloid Peptide Fibrils
2004
Binding of atrial and brain natriuretic peptides in brains of hypertensive rats
1990
Hospitalization for Ambulatory Care-Sensitive Conditions: A Method for Comparative Access and Quality Studies Using Routinely Collected Statistics
2001
PPARγ activation enhances cell surface ENaCα via up‐regulation of SGK1 in human collecting duct cells
2003
In Vivo Detection of Macrophages in Human Carotid Atheroma
2004
Glucose Transporters in Human Renal Proximal Tubular Cells Isolated From the Urine of Patients With Non–Insulin-Dependent Diabetes
2005
Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages
2006